浅析肝硬化食管胃底静脉破裂出血的内科治疗方法

A Brief Analysis of the Medical Treatment of the Rupture of Esophageal and Gastric Fundus Hemorrhage in Cirrhosis

目的浅析肝硬化合并食管胃底静脉出血患者的内科治疗方法。方法收集80例肝硬化食管胃底静脉破裂出血患者的临床资料,依据简单随机法将所选患者分为A组和B组,每组40例。A组采用常规治疗方法,B组在A组基础上加用生长抑素,观察两组临床治疗效果的差异。结果 B组止血有效率明显高于A组(P<0.05),B组出血复发率明显低于A组(P<0.05),B组止血时间和住院时间明显低于A组(P<0.05)。结论对于本病的治疗,常规药物加用生长抑素止血效果显著。对出血量较大难以控制的患者,采用药物加介入综合治疗可取得满意的临床预期。

Objective to analyze the therapeutic methods of liver cirrhosis combined with esophageal and gastric fundus hemorrhage. Methods the clinical data of 80 patients with esophageal and gastric fundus venous hemorrhage were collected, and the selected patients were divided into Group A and group B with 40 cases in each group according to the simple stochastic method. Routine treatment was applied in group A, and somatostatin was added to group B on the basis of group A to observe the difference in clinical treatment effect between the two groups. Results the effective rate of hemostasis in group B was significantly higher than that in group A（P〈0.05）. The recurrence rate of bleeding in group B was significantly lower than that in group A（P〈0.05）. The time of hemostasis and hospitalization in group B was significantly lower than that in group A（P〈0.05）. Conclusion for the treatment of this disease, the effect of somatostatin on hemostasis is remarkable.For patients with large bleeding that is difficult to control, the combination of drug and interventional therapy can achieve satisfactory clinical expectations.